Literature DB >> 24077953

Insights on the genotype distribution among Cryptococcus neoformans and C. gattii Portuguese clinical isolates.

A P Maduro, K Mansinho, F Teles, I Silva, W Meyer, M L Martins, J Inácio.   

Abstract

This study provides a comprehensive picture of the C. neoformans/C. gattii molecular types most often associated with human cryptococcosis in Portugal and assesses the impact of C. gattii in these infections. One hundred and twenty-two clinical isolates, from distinct patients, were identified as C. neoformans and genotyped by URA5-RFLP, with the molecular types VNI (45.5 %) and VNIII (30.9 %) being the most commonly found ones. The molecular types VNII (11.4 %) and VNIV (11.4 %) were less abundant. One patient was found to be infected with a VGII isolate. This patient exhibited unusual clinical symptoms of cryptococcosis, reinforcing the suspicion for the presence of a different genotypic pattern, as determined afterwards. This case was detected in 2007 and is the first report of a potential autochthonous C. gattii infection case in Portugal, as the patient revealed no historical record of travelling outside the country.

Entities:  

Mesh:

Year:  2014        PMID: 24077953     DOI: 10.1007/s00284-013-0452-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  21 in total

1.  Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting.

Authors:  T C Sorrell; S C Chen; P Ruma; W Meyer; T J Pfeiffer; D H Ellis; A G Brownlee
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

2.  First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain.

Authors:  M Francisca Colom; Susana Frasés; Consuelo Ferrer; Alejandro Jover; Mariano Andreu; Sergio Reus; Manuel Sánchez; Josep M Torres-Rodríguez
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains.

Authors:  L R Martinez; J Garcia-Rivera; A Casadevall
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 4.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

5.  In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.

Authors:  Hin Siong Chong; Rebecca Dagg; Richard Malik; Sharon Chen; Dee Carter
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

6.  Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment.

Authors:  María Francisca Colom; Ferry Hagen; Alfonso Gonzalez; Axelle Mellado; Neus Morera; Carlos Linares; David F García; Joaquín S Peñataro; Teun Boekhout; Manuel Sánchez
Journal:  Med Mycol       Date:  2011-04-26       Impact factor: 4.076

Review 7.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

8.  Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Authors:  Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

9.  Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.

Authors:  S Lucas; M da Luz Martins; O Flores; W Meyer; I Spencer-Martins; J Inácio
Journal:  Clin Microbiol Infect       Date:  2009-08-20       Impact factor: 8.067

10.  Disseminated Cryptococcus neoformans var. grubii infections in intensive care units.

Authors:  Y-M Chuang; S C Ku; S J Liaw; S C Wu; Y C Ho; C J Yu; P R Hsueh
Journal:  Epidemiol Infect       Date:  2009-10-02       Impact factor: 2.451

View more
  6 in total

1.  Factors enforcing the species boundary between the human pathogens Cryptococcus neoformans and Cryptococcus deneoformans.

Authors:  Shelby J Priest; Marco A Coelho; Verónica Mixão; Shelly Applen Clancey; Yitong Xu; Sheng Sun; Toni Gabaldón; Joseph Heitman
Journal:  PLoS Genet       Date:  2021-01-19       Impact factor: 5.917

2.  HIV/AIDS-Associated Cryptococcosis in Portugal Spanning the Pre- to Post-HAART Era: A Retrospective Assessment at the Genotypic Level Based on URA5-RFLP.

Authors:  A P Maduro; L Gonçalves; J Inácio; N C G Faria; M L Martins; F R R Teles
Journal:  Curr Microbiol       Date:  2015-07-14       Impact factor: 2.188

3.  Cryptococcal infection in non-HIV immunosuppressed patients - Three case reports in a nephrology setting.

Authors:  Pedro Ventura Aguiar; Virgínia Lopes; La Salete Martins; Josefina Santos; Manuela Almeida; Sofia Pedroso; Leonídio Dias; António Castro Henriques; Helena Ramos; António Cabrita
Journal:  Med Mycol Case Rep       Date:  2013-12-04

4.  Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.

Authors:  Jairo Lizarazo; Patricia Escandón; Clara Inés Agudelo; Carolina Firacative; Wieland Meyer; Elizabeth Castañeda
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

5.  Blepharitis due to Cryptococcus neoformans in a cat from northern Portugal.

Authors:  Paulo Pimenta; Sofia Alves-Pimenta; João Barros; Maria J Pereira; Luís Maltez; A Paula Maduro; Luís Cardoso; Ana C Coelho
Journal:  JFMS Open Rep       Date:  2015-07-06

6.  Ferrets as sentinels of the presence of pathogenic Cryptococcus species in the Mediterranean environment.

Authors:  Neus Morera; Ferry Hagen; Carles Juan-Sallés; Carlos Artigas; Rui Patricio; Juan Ignacio Serra; Ma Francisca Colom
Journal:  Mycopathologia       Date:  2014-06-25       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.